CPT1A and colorectal carcinoma: More importantly, our data showed that dihydroartemisinin treatments significantly reduced the mRNA levels (Fig. 4E–H) and protein expressions (Fig. 4I, J) of ACC, FASN, CPT-1, and MCAD in these CRC cells, and in the tumors of the CRC-bearing xenograft mouse models (Fig. 4K).